Eris Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has submitted a routine quarterly compliance certificate to the stock exchanges for the quarter ended 30 June 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (MUFG Intime India Private Limited, formerly Link Intime), confirms that all share certificates received for dematerialisation during the quarter were properly processed and confirmed to the depositories. It also confirms that physical certificates received were mutilated and cancelled, and the depository's name has been substituted as the registered owner in the company's register of members within the required timelines. This is a standard regulatory filing mandated under SEBI's depository regulations with no business or financial details disclosed.
This is a routine procedural compliance filing with no material impact on the company's operations, financials, or shareholder value. Investors can ignore it as it does not affect the stock price or any corporate action.